Correlation Between Cannabics Pharmaceuticals and Galera Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cannabics Pharmaceuticals and Galera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannabics Pharmaceuticals and Galera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cannabics Pharmaceuticals and Galera Therapeutics, you can compare the effects of market volatilities on Cannabics Pharmaceuticals and Galera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannabics Pharmaceuticals with a short position of Galera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannabics Pharmaceuticals and Galera Therapeutics.

Diversification Opportunities for Cannabics Pharmaceuticals and Galera Therapeutics

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between Cannabics and Galera is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Cannabics Pharmaceuticals and Galera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Galera Therapeutics and Cannabics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannabics Pharmaceuticals are associated (or correlated) with Galera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Galera Therapeutics has no effect on the direction of Cannabics Pharmaceuticals i.e., Cannabics Pharmaceuticals and Galera Therapeutics go up and down completely randomly.

Pair Corralation between Cannabics Pharmaceuticals and Galera Therapeutics

If you would invest  258.00  in Galera Therapeutics on September 5, 2024 and sell it today you would earn a total of  0.00  from holding Galera Therapeutics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy4.55%
ValuesDaily Returns

Cannabics Pharmaceuticals  vs.  Galera Therapeutics

 Performance 
       Timeline  
Cannabics Pharmaceuticals 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Cannabics Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental drivers, Cannabics Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Galera Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Galera Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Galera Therapeutics is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Cannabics Pharmaceuticals and Galera Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cannabics Pharmaceuticals and Galera Therapeutics

The main advantage of trading using opposite Cannabics Pharmaceuticals and Galera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannabics Pharmaceuticals position performs unexpectedly, Galera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Galera Therapeutics will offset losses from the drop in Galera Therapeutics' long position.
The idea behind Cannabics Pharmaceuticals and Galera Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators